Glycyrrhizin ameliorates inflammatory pain by inhibiting microglial activation-mediated inflammatory response via blockage of the HMGB1-TLR4-NF-kB pathway

Experimental Cell Research
Xiaojuan SunHongxing Zhang

Abstract

Chronic inflammatory pain is a severe clinical problem that greatly affects patients' quality of life and causes huge economic burden. Microglia-mediated neuroinflammation exerts critical roles in the pathogenic progression of inflammatory pain. Recent evidence corroborates the anti-inflammatory and neuroprotective efficacy of glycyrrhizin; however, its function in inflammatory pain remains poorly elucidated. In the present study, glycyrrhizin suppressed LPS-induced activation of microglial cell BV2 by inhibiting NO production and expression of microglial marker IBA-1. Intriguingly, LPS-induced high expression and generation of inflammatory cytokines (i.e., IL-6, TNF-α and IL-1β) was notably reversed by glycyrrhizin pre-treatment. Mechanistic analysis confirmed that high expression of high-mobility group box 1 (HMGB1) in LPS-activated microglia was inhibited following glycyrrhizin. More importantly, restoring HMGB1 expression by recombinant adenovirus vector of Ad-HMGB1 counteracted glycyrrhizin-restrained inflammatory response in microglia upon LPS stimulation. Furthermore, glycyrrhizin dampened the activation of subsequent TLR4-NF-κB pathway in LPS-stimulated microglia, which was abrogated by HMGB1 elevation. Furthermore, blo...Continue Reading

Citations

May 13, 2020·Journal of Cellular Physiology·Seyed Omar EbrahimiSalar Shareef
Dec 28, 2019·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Junliang QianJi-Tian Xu
Oct 18, 2018·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·Li LiuJena J Steinle
Jul 7, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Francesco MaioneStefano Pieretti
Feb 26, 2019·Journal of Cellular Physiology·Yong ZhangXiaoming Lei
Jul 1, 2020·Evidence-based Complementary and Alternative Medicine : ECAM·Xiao-Min ZhangLing-Ling Zhu
Dec 22, 2020·Evidence-based Complementary and Alternative Medicine : ECAM·Ho-Sung LeeDae-Yeon Lee
Jun 24, 2019·European Journal of Pharmacology·Yam Nath PaudelMohd Farooq Shaikh
Feb 8, 2020·Current Neuropharmacology·Shareen Singh, Thakur Gurjeet Singh
May 1, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Takahiro KochiNorimitsu Morioka
May 7, 2021·Journal of Medicinal Chemistry·Samuel ObengChristopher R McCurdy
Oct 16, 2019·Current Medicinal Chemistry·Kun ChenHai-Liang Zhu
Aug 6, 2021·Therapeutic Advances in Psychopharmacology·Rae F BellJari Yli-Kauhaluoma
Jan 24, 2020·ACS Chemical Neuroscience·Yam Nath PaudelMohd Farooq Shaikh
Aug 25, 2020·Acta Pharmaceutica Sinica. B·Yanfang XianHongxi Xu
Dec 30, 2021·Natural Product Research·Angelo FumiaAlessio Alesci

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atopic Dermatitis

Atopic dermatitis is a chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. Discover the latest research on atopic dermatitis here.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here